- Home
- GILD vs SHOP Comparison
GILD vs SHOP Comparison
Compare GILD & SHOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GILD
- SHOP
- Stock Information
- Founded
- GILD 1987
- SHOP 2004
- Country
- GILD United States
- SHOP Canada
- Employees
- GILD N/A
- SHOP N/A
- Industry
- GILD Biotechnology: Biological Products (No Diagnostic Substances)
- SHOP Computer Software: Prepackaged Software
- Sector
- GILD Health Care
- SHOP Technology
- Exchange
- GILD Nasdaq
- SHOP Nasdaq
- Market Cap
- GILD 133.3B
- SHOP 121.7B
- IPO Year
- GILD 1992
- SHOP 2015
- Fundamental
- Price
- GILD $111.73
- SHOP $112.67
- Analyst Decision
- GILD Buy
- SHOP Buy
- Analyst Count
- GILD 25
- SHOP 32
- Target Price
- GILD $110.17
- SHOP $114.16
- AVG Volume (30 Days)
- GILD 8.9M
- SHOP 8.3M
- Earning Date
- GILD 08-07-2025
- SHOP 08-06-2025
- Dividend Yield
- GILD 2.83%
- SHOP N/A
- EPS Growth
- GILD 1118.07
- SHOP N/A
- EPS
- GILD 4.73
- SHOP 1.23
- Revenue
- GILD $28,735,000,000.00
- SHOP $9,379,000,000.00
- Revenue This Year
- GILD $1.59
- SHOP $25.02
- Revenue Next Year
- GILD $3.67
- SHOP $19.88
- P/E Ratio
- GILD $23.62
- SHOP $91.75
- Revenue Growth
- GILD 4.68
- SHOP 26.52
- 52 Week Low
- GILD $66.01
- SHOP $48.56
- 52 Week High
- GILD $119.96
- SHOP $129.38
- Technical
- Relative Strength Index (RSI)
- GILD 58.05
- SHOP 56.58
- Support Level
- GILD $104.46
- SHOP $108.33
- Resistance Level
- GILD $112.00
- SHOP $116.60
- Average True Range (ATR)
- GILD 2.78
- SHOP 3.57
- MACD
- GILD 0.05
- SHOP 0.23
- Stochastic Oscillator
- GILD 89.70
- SHOP 65.12
About GILD Gilead Sciences Inc.
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).
About SHOP Shopify Inc.
Shopify offers an e-commerce platform primarily to small and medium-size businesses. The firm has two segments. The subscription solutions segment allows Shopify merchants to conduct e-commerce on a variety of platforms, including the company's website, physical stores, pop-up stores, kiosks, social networks (Facebook), and Amazon. The merchant solutions segment offers add-on products for the platform that facilitate e-commerce and include Shopify Payments, Shopify Shipping, and Shopify Capital.